Trials / Completed
CompletedNCT00460187
EPIC US Pivotal Study
Evaluating the Use of the FiberNet Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 237 (actual)
- Sponsor
- Lumen Biomedical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, prospective, pivotal study designed to demonstrate the safety and efficacy of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention in high surgical risk patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous intervention of the carotid artery |
Timeline
- Start date
- 2007-03-01
- Completion
- 2008-06-01
- First posted
- 2007-04-13
- Last updated
- 2008-10-21
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00460187. Inclusion in this directory is not an endorsement.